There is no single “best” medication for generalized anxiety disorder, but the strongest evidence points to a small group of antidepressants as the most effective and well-tolerated options. International guidelines consistently recommend SSRIs and SNRIs as first-line treatment, with escitalopram, duloxetine, and venlafaxine ranking highest in large comparative analyses.
First-Line Medications for GAD
SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors) are the foundation of GAD treatment. Both work by increasing serotonin activity in the brain, which helps quiet the overactive fear circuits believed to drive chronic anxiety. SNRIs also boost norepinephrine, which can provide additional benefit for the physical symptoms of anxiety like muscle tension and fatigue.
A major meta-analysis found that among all medications studied, escitalopram (Lexapro), duloxetine (Cymbalta), and venlafaxine (Effexor) appear to be the most effective and well tolerated. The World Federation of Societies of Biological Psychiatry gives its highest recommendation to these specific drugs, along with paroxetine (Paxil) and sertraline (Zoloft). All carry strong evidence from multiple randomized controlled trials showing clear superiority over placebo.
If you’re starting treatment for the first time, your prescriber will likely suggest one of these five medications. Escitalopram and sertraline tend to be tried first because they generally cause fewer side effects than the others. Duloxetine or venlafaxine may be preferred if you also experience significant physical tension or chronic pain alongside your anxiety.
How Long Before They Work
One of the most frustrating aspects of GAD medication is the wait. SSRIs and SNRIs typically take several weeks to become fully effective. Most people notice some improvement within the first two weeks, but the full therapeutic benefit often takes four to six weeks to develop. This delay is one reason benzodiazepines are sometimes prescribed alongside an antidepressant during those early weeks, to provide faster relief while the primary medication builds up.
If your first medication doesn’t work well enough after six to eight weeks at an adequate dose, switching to a different SSRI or SNRI is the usual next step. The drugs in this class are similar but not identical, and it’s common to try two or three before finding the right fit.
Pregabalin: A Different Approach
Pregabalin (Lyrica) works through a completely different mechanism than antidepressants. It modulates calcium channels in the nervous system, essentially dialing down the excitability of nerve cells involved in anxiety. International guidelines place it alongside SSRIs and SNRIs as a first-line option, based on strong clinical trial evidence.
In head-to-head trials, pregabalin at doses of 300 to 600 mg per day produced anxiety reductions comparable to venlafaxine, with one potential advantage: it may start working faster. Clinical trials showed meaningful symptom improvement within the first week for some patients. It also performed well across both the psychological symptoms of anxiety (worry, apprehension) and the physical ones (restlessness, sleep disruption, muscle tension).
Pregabalin tends to be better tolerated than venlafaxine and benzodiazepines in clinical comparisons. Dizziness and drowsiness are the most common side effects. While it carries less dependence risk than benzodiazepines, it’s not zero risk, and tapering rather than abruptly stopping is recommended. Pregabalin is widely used for GAD in Europe but is not FDA-approved for anxiety in the United States, which means American prescribers may be less familiar with this use.
Buspirone: Mixed Evidence
Buspirone is often mentioned in older treatment guides as an option for GAD, but the evidence supporting it is inconsistent. The WFSBP rates it at the lowest recommendation level, noting that positive trial results are roughly balanced by negative ones. It doesn’t cause dependence and has a mild side effect profile, which makes it appealing in theory. In practice, many patients and clinicians find it less reliably effective than SSRIs or SNRIs. It’s reasonable to try if first-line options haven’t worked or aren’t tolerated, but it’s not where most treatment starts.
Benzodiazepines: Effective but Limited
Benzodiazepines like alprazolam (Xanax), diazepam (Valium), and lorazepam (Ativan) reduce anxiety quickly, often within 30 to 60 minutes. That speed makes them useful in two situations: during an acute anxiety crisis, or as a bridge during the first four to six weeks while an SSRI or SNRI takes effect.
Guidelines from multiple international bodies agree that benzodiazepines should generally be limited to four to eight weeks of use. Beyond that window, the risks of sedation, cognitive impairment, physical dependence, and difficult withdrawal begin to outweigh the benefits. Long-term benzodiazepine use is only considered appropriate in rare cases where multiple other treatments have failed, and never for people with a history of substance misuse. If you’re currently taking a benzodiazepine daily for anxiety, don’t stop abruptly. Tapering under medical guidance is important to avoid withdrawal symptoms.
Second-Line and Add-On Options
When first-line medications don’t provide enough relief, several backup options exist. The older antidepressant imipramine (a tricyclic) has solid evidence for GAD but carries more side effects and a higher risk of serious problems in overdose, which is why it’s reserved for second-line use. Hydroxyzine, an antihistamine, has shown effectiveness in controlled studies, though significant drowsiness limits its practicality for daytime use.
For treatment-resistant cases, low doses of certain atypical antipsychotics (quetiapine, risperidone, or olanzapine) are sometimes added to an SSRI. The evidence here is preliminary, and these medications come with their own side effect concerns, including weight gain and metabolic changes. They’re typically a last resort rather than a routine option.
Why the “Best” Medication Varies by Person
The reason no single drug is universally best comes down to individual biology. Two people with identical GAD symptoms can respond very differently to the same medication. Genetic differences in how your body processes drugs play a meaningful role. Pharmacogenetic testing, which analyzes gene variants that affect drug metabolism, has shown promise in improving outcomes. In one randomized trial, patients whose medication was selected using genetic test results had significantly better anxiety scores at both 8 and 12 weeks compared to those treated with standard prescribing, with nearly twice the odds of responding well.
This kind of testing isn’t yet standard practice everywhere, but it’s increasingly available and may be worth asking about if you’ve tried multiple medications without success. Beyond genetics, your specific symptom pattern matters too. If physical symptoms like muscle tension and sleep disruption dominate, an SNRI or pregabalin may outperform an SSRI. If you’re also dealing with depression, an SSRI or SNRI addresses both conditions simultaneously.
For most people starting treatment, escitalopram or sertraline is a reasonable first choice based on the balance of efficacy, tolerability, and cost. But the best medication for your GAD is ultimately the one that reduces your symptoms without side effects you can’t live with, and finding it sometimes takes patience and more than one try.